Abstract
Prolyl oligopeptidase family enzymes regulate the activity of biologically active peptides and peptide hormones, and they are implicated in diseases, including amnesia, depression, diabetes, and trypanosomiasis. Distinctively, these enzymes hydrolyze only relatively short peptide substrates, while large structured peptides and proteins are not usually cleaved. Prolyl oligopeptidase has a C-terminal α/β-hydrolase catalytic domain that is similar to lipases and esterases. An N-terminal β-propeller domain regulates access to the buried active site, explaining the observed oligopeptidase activity. The catalytic and regulatory mechanisms have been investigated using a combination of X-ray crystallography, site-directed mutagenesis, and enzyme kinetic measurements. Crystal structures have now been determined for representative members of three of the four subfamilies and are facilitating a better understanding of the structure-function properties of these physiologically and pharmaceutically important enzymes.
Similar content being viewed by others
References
Puente, X. S., Sanchez, L. M., Overall, C. M. and Lopez-Otin, C. (2003) Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4, 544–558.
Rawlings, N. D., Tolle, D. P., and Barrett, A. J. (2004) MEROPS: the peptidase database. Nucleic Acids Res. 32, 160–164.
Holmquist, M. (2000) Alpha/beta-hydrolase fold enzymes: structures, functions and mechanisms. Curr. Protein Pept. Sci. 1, 209–235.
Dodson, G. and Wlodawer, A. (1998) Catalytic triads and their relatives. Trends Biochem. Sci. 23, 347–352.
Venalainen, J. I., Juvonen, R. O., and Mannisto, P. T. (2004) Evolutionary relationships of the prolyl oligopeptidase family enzymes. Eur. J. Biochem. 271, 2705–2715.
Walter, R., Shlank, H., Glass, J. D., Schwartz, I. L., and Kerenyi, T. D. (1971) Leucylglycinamide released from oxytocin by human uterine enzyme. Science 173, 827–829.
Koida, M. and Walter, R. (1976) Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J. Biol. Chem. 251, 7593–7599.
Wilk, S. (1983) Prolyl endopeptidase. Life Sci. 33, 2149–2157.
Mentlein, R. (1988) Proline residues in the maturation and degradation of peptide-hormones and neuropeptides. FEBS Lett. 234, 251–256.
Cunningham, D. F. and O’Connor, B. (1997) Proline specific peptidases. Biochim. Biophys. Acta 1343, 160–186.
Maes, M., Goossens, F., Scharpe, S., Meltzer, H. Y., D’Hondt, P., and Cosyns, P. (1994) Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol. Psychiatry 35, 545–552.
Maes, M., Goossens, F., Scharpe, S., Calabrese, J., Desnyder, R., and Meltzer, H. Y. (1995) Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res. 58, 217–225.
Yoshimoto, T., Kado, K., Matsubara, F., Koriyama, N., Kaneto, H. and Tsuru, D. (1987) Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J. Pharmacobiodyn. 10, 730–735.
Morain, P., Lestage, P., De Nanteuil, G., et al. (2002) S17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS Drug Rev. 8, 31–52.
Shinoda, M., Toide, K., Ohsawa, I., and Kohsaka, S. (1997) Specific inhibitor for prolyl endopeptidase suppresses the generation of amiloid βprotein in NG108-15 cells. Biochem. Biophys. Res. Commun. 235, 641–645.
Kato, A., Fukunari, A., Sakai, Y., and Nakajima, Z. (1997) Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse. J. Pharmacol. Exp. Ther. 283, 328–335.
Petit, A., Barelli, H., Morain, P., and Checler, F. (2000) Novel proline endopeptidase inhibitors do not modify Aβ40/42 formation and degradation by human cells expressing wild-type and Swedish mutated β-amyloid precursor protein. Br. J. Pharmacol. 130, 1613–1617.
Welches, W. R., Brosnihan, K. B., and Ferrario, C. M. (1993) A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase. Life Sci. 52, 1461–1480.
Santana, J. M., Grellier, P., Schrevel, J., and Teixeira, A. R. (1997) A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem. J. 325, 129–137.
Grellier, P., Vendeville, S., Joyeau, R., et al. (2001) Trypanosoma cruzi prolyl oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes. J. Biol. Chem. 276, 47,078–47,086.
Bastos, I. M., Grellier, P., Martins, N. F., et al. (2005) Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80) that is required for parasite entry into mammalian cells. Biochem. J. 388, 29–38.
Fülöp, V., Böcskei, Z., and Polgár, L. (1998) Prolyl oligopeptidase: an unusual β-propeller domain regulates proteolysis. Cell 94, 161–170.
Wall, M. A., Coleman, D. E., Lee, E., et al. (1995) The structure of the G protein heterotrimer Giα1β1γ2. Cell 83, 1047–1058.
Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B. (1996) The 2.0 A crystal structure of a heterotrimeric G protein. Nature 379, 311–319.
Sondek, J., Bohm, A., Lambright, D. G., Hamm, H. E., and Sigler, P. B. (1996) Crystal structure of a G-protein βγ dimer at 2.1A resolution. Nature 379, 369–374.
Baker, S. C., Saunders, N. F., Willis, A. C., Ferguson, S. J., Hajdu, J., and Fülöp, V. (1997) Cytochrome cd 1 structure: unusual haem environments in a nitrite reductase and analysis of factors contributing to β-propeller folds. J. Mol. Biol. 269, 440–455.
Fülöp, V. and Jones, D. T. (1999) β-Propellers: structural rigidity and functional diversity. Curr. Opin. Struct. Biol. 9, 715–721.
Faber, H. R., Groom, C. R., Baker, H. M., Morgan, W. T., Smith, A., and Baker, E. N. (1995) 1.8 Å structure of the C-terminal domain of rabbit serum hemopexin. Structure 3, 551–559.
Li, J., Brick, P., O’Hare, M. C., et al. (1995) Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed β-propeller. Structure 3, 341–349.
Polgár, L. (1991). pH-dependent mechanism in the catalysis of prolyl endopeptidase from pig muscle. Eur. J. Biochem. 197, 441–447.
Polgár, L. (1992) Prolyl endopeptidase catalysis. A physical rather than a chemical step is rate-limiting. Biochem. J. 283, 647–648.
Fülöp, V., Szeltner, Z., and Polgár, L. (2000) Catalysis of serine oligopeptidases is controlled by a gating filter mechanism. EMBO Rep. 1, 277–281.
Szeltner, Z., Rea, D., Juhász, T., Renner, V., Fülöp, V., and Polgár, L. (2004) Concerted structural changes in the peptidase and the propeller domains of prolyl oligopeptidase are required for substrate binding. J. Mol. Biol. 340, 627–637.
Hasebe, T., Hua, J., Someya, A., Morain, P., Checler, F., and Nagaoka, I. (2001) Involvement of cytosolic prolyl endopeptidase in degradation of p40-phox splice variant protein in myeloid cells. J. Leukoc. Biol. 69, 963–968.
Shan, L., Mathews, I. I., and Khosla, C. (2005) Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity. Proc. Natl. Acad. Sci. U.S.A. 102, 3599–3604.
Harris, M. N., Madura, J. D., Ming, L. J., and Harwood, V. J. (2001) Kinetic and mechanistic studies of prolyl oligopeptidase from the hyperthermophile Pyrococcus furiosus. J. Biol. Chem. 276, 19,310–19,317.
Fülöp, V., Szeltner, Z., Renner, V., and Polgár, L. (2001) Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue. J. Biol. Chem. 276, 1262–1266.
Szeltner, Z., Rea, D., Renner, V., Juliano, L., Fülöp, V., and Polgár, L. (2003) Electrostatic environment at the active site of prolyl oligopeptidase is highly influential during substrate binding. J. Biol. Chem. 278, 48,786–48,793.
Rosenblum, J. S. and Kozarich, J. W. (2003) Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr. Opin. Chem. Biol. 7, 496–504.
Polgár, L., Kollát, E., and Hollósi, M. (1993) Prolyl oligopeptidase catalysis. Reactions with thiono substrates reveal substrate-induced conformational change to be the rate-limiting step. FEBS Lett. 322, 227–230.
Szeltner, Z., Rea, D., Renner, V., Fülöp, V., and Polgár, L. (2002) Electrostatic effects and binding determinants in the catalysis of prolyl oligopeptidase. Site-specific mutagenesis at the oxyanion binding site. J. Biol. Chem. 277, 42,613–42,622.
Cygler, M., Schrag, J. D., Sussman, J. L., et al. (1993) Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Protein Sci. 2, 366–382.
Halkides, C. J., Wu, Y. Q., and Murray, C. J. (1996). A low-barrier hydrogen bood in subtilisin: 1H and 15N NMR studies with peptidyl trifluoromethyl ketones. Biochemistry 35, 15,941–15,948.
Craik, C. S., Roczniak, S., Largman, C., and Rutter, W. J. (1987) The catalytic role of the active site aspartic acid in serine proteases. Science 237, 909–913.
Sprang, S., Standing, T., Fletterick, R. J., et al. (1987) The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. Science 237, 905–909.
Szeltner, Z., Rea, D., Juhasz, T., et al. (2002) Substrate-dependent competency of the catalytic triad of prolyl oligopeptidase. J. Biol. Chem. 277, 44,597–44,605.
Fersht, A. R. (1987) Structure and Mechanism in Protein Sciences: A Guide to Enzyme Catalysis and Protein Folding, WH Freeman & Company, New York.
Liang, T. C. and Abeles, R. H. (1987) Complex of α-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone: structural studies with NMR spectroscopy. Biochemistry 26, 7603–7608.
Matthews, D. A., Alden, R. A., Birktoft, J. J., Freer, S. T., and Kraut, J. (1975) X-ray crystallographic study of boronic acid adducts with subtilisin BPN′ (Novo). A model for the catalytic transition state. J. Biol. Chem. 250, 7120–7126.
Bryan, P., Pantoliano, M. W., Quill, S. G., Hsiao, H. Y., and Poulos, T. (1986) Site-directed mutagenesis and the role of the oxyanion hole in subtilisin. Proc. Natl. Acad. Sci. U.S.A. 83, 3743–3745.
Braxton, S. and Wells, J. A. (1991) The importance of a distal hydrogen bonding group in stabilizing the transition state in subtilisin BPN′. J. Biol. Chem. 266, 11,797–11,800.
Engel, M., Hoffmann, T., Wagner, L., et al. (2003) The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Proc. Natl. Acad. Sci. U.S.A. 100, 5063–5068.
Hiramatsu, H., Kyono, K., Higashiyama, Y., et al. (2003) The structure and function of human dipeptidyl peptidase IV, possessing a unique eight-bladed β-propeller fold. Biochem. Biophys. Res. Commun. 302, 849–854.
Oefner, C., D’Arcy, A., Mac Sweeney, A., Pierau, S., Gardiner, R., and Dale, G. E. (2003) High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[([2-[(5-iodopyridin-2-yl) amino]-ethyl]amino)-acetyl]-2-cyano-(S)-pyrrolidine. Acta Crystallogr. D 59, 1206–1212.
Rasmussen, H. B., Branner, S., Wiberg, F. C., and Wagtmann, N. (2003) Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Nat. Struct. Biol. 10, 19–25.
Thoma, R., Loffler, B., Stihle, M., Huber, W., Ruf, A., and Hennig, M. (2003) Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure 11, 947–959.
Larsen, N. A., Turner, J. M., Stevens, J. et al. (2002) Crystal structure of a bacterial cocaine esterase. Nat. Struct. Biol. 9, 17–21.
Szeltner, Z., Renner, V., and Polgár, L. (2000) Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family. Protein Sci. 9, 353–360.
Polgár, L. (1997) A potential processing enzyme in prokaryotes: oligopeptidase B, a new type of serine peptidase. Proteins 28, 375–379.
Caler, E. V., Vaena de Avalos, S., Haynes, P. A., Andrews, N. W., and Burleigh, B. A. (1998) Oligopeptidase B-dependent signalling mediates host cell invasion by Trypanosoma cruzi. EMBO J. 17, 4975–4986.
Caler, E. V., Morty, R. E., Burleigh, B. A., and Andrews, N. W. (2000) Dual role of signaling pathways leading to Ca2+ and cyclic AMP elevation in host cell invasion by Trypanosoma cruzi. Infect. Immun. 68, 6602–6610.
Morty, R. E., Lonsdale-Eccles, J. D., Morehead, J., et al. (1999) Oligopeptidase B from Trypanosoma brucei, a new member of an emerging subgroup of serine oligopeptidases. J. Biol. Chem. 274, 26,149–26,156.
Morty, R. E., Lonsdale-Eccles, J. D., Mentele, R., Auerswald, E. A., and Coetzer, T. H. (2001) Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity. Infect. Immun. 69, 2757–2761.
Morty, R. E., Authie, E., Troeberg, L., Lonsdale-Eccles, J. D., and Coetzer, T. H. (1999) Purification and characterisation of a trypsin-like serine oligopeptidase from Trypanosoma congolense. Mol. Biochem. Parasitol. 102, 145–155.
Morty, R. E., Pelle, R., Vadasz, I., Uzcanga, G. L., Seeger, W., and Bubis, J. (2005) Oligopeptidase B from Trypanosoma evansi: a parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts. J. Biol. Chem. 280, 10,925–10,937.
Morty, R. E., Troeberg, L., Pike, R. N., et al. (1998) A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin. FEBS Lett. 433, 251–256.
Morty, R. E., Troeberg, L., Powers, J. C., Ono, S., Lonsdale-Eccles, J. D., and Coetzer, T. H. (2000) Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters. Biochem. Pharmacol. 60, 1497–1504.
Tsuji, A., Yuasa, K., and Matsuda, Y. (2004) Identification of oligopeptidase B in higher plants. Purification and characterization of oligopeptidase B from quiescent wheat embryo, Triticum aestivum. J. Biochem. 136, 673–681.
Tsuru, D. and Yoshimoto, T. (1994) Oligopeptidase B: protease II from Escherichia coli. Methods Enzymol. 244, 201–215.
Barrett, A. J., Rawlings, N. D., and Woessner, J. F. (2004) Handbook of Proteolytic Enzymes, Academic Press, London.
Burleigh, B. A., Caler, E. V., Webster, P., and Andrews, N. W. (1997) A cytosolic serine endopeptidase from Trypanosoma cruzi is required for the generation of Ca2+ signalling in mammalian cells. J. Cell. Biol. 136, 609–620.
Gérczei, T., Keserü, G. M., and Náray-Szabó, G. (2000) Construction of a 3D model of oligopeptidase B, a potential processing enzyme in prokaryotes. J. Mol. Graph. Model. 18, 7–17.
Morty, R. E., Fülöp, V., and Andrews N. W. (2002) Substrate recognition properties of oligopeptidase B from Salmonella enterica serovar Typhimurium. J. Bacteriol. 184, 3329–3337.
Polgár, L. (1999) Oligopeptidase B: a new type of serine peptidase with a unique substrate-dependent temperature sensitivity. Biochemistry 38, 15,548–15,555.
Hemerly, J. P., Oliveira, V., Del Nery, E., et al. (2003) Subsite specificity (S3, S2, S1′, S2′ and S3′) of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity. Biochem. J. 373, 933–939.
Yoshimoto, T., Tabira, J., Kabashima, T., Inoue, S., and Ito, K. (1995) Protease II from Moraxella lacunata: cloning, sequencing, and expression of the enzyme gene, and crystallization of the expressed enzyme. J. Biochem. 117, 654–660.
Elovson, J. (1980) Biogenesis of plasma membrane glycoproteins. Purification and properties of two rat liver plasma membrane glycoproteins. J. Biol. Chem. 255, 5807–5815.
Durinx, C., Lambeir, A. M., Bosmans, E., et al. (2000) Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur. J. Biochem. 267, 5608–5613.
Aertgeerts, K., Ye, S., Shi, L., et al. (2004) N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Protein Sci. 13, 145–154.
Tiruppathi, C., Ganapathy, V., and Leibach, F. H. (1990) Evidence for tripeptide-proton symport in renal brush border membrane vesicles. Studies in a novel rat strain with a genetic absence of dipeptidyl peptidase IV. J. Biol. Chem. 265, 2048–2053.
Suzuki, Y., Erickson, R. H., Sedlmayer, A., Chang, S. K., Ikehara, Y., and Kim, Y. S. (1993) Dietary regulation of rat intestinal angiotensin-converting enzyme and dipeptidyl peptidase IV. Am. J. Physiol. 264, 1153–1159.
Drucker, D. J. (2001) Minireview: the glucagon-like peptides. Endocrinology 142, 521–527.
Ansorge, S., Buhling, F., Kahne, T., et al. (1997) CD26/dipeptidyl peptidase IV in lymphocyte growth regulation. Adv. Exp. Med. Biol. 421, 127–140.
Kahne, T., Lendeckel, U., Wrenger, S., Neubert, K., Ansorge, S., and Reinhold, D. (1999) Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). Int. J. Mol. Med. 4, 3–15.
Ludwig, A., Schiemann, F., Mentlein, R., Lindner, B., and Brandt, E. (2002) Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J. Leukoc. Biol. 72, 183–191.
Ludwig, K., Fan, H., Dobers, J., Berger, M., Reutter, W., and Bottcher, C. (2004) 3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis. Biochem. Biophys. Res. Commun. 313, 223–229.
Cheng, H. C., Abdel-Ghany, M., and Pauli, B. U. (2003) A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J. Biol. Chem. 278, 24,600–24,607.
Loster, K., Zeilinger, K., Schuppan, D., and Reutter, W. (1995) The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem. Biophys. Res. Commun. 217, 341–348.
Blanco, J., Valenzuela, A., Herrera, C., Lluis, C., Hovanessian, A. G., and Franco, R. (2000) The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression. FEBS Lett. 477, 123–128.
Herrera, C., Morimoto, C., Blanco, J., et al. (2001) Comodulation of CXCR4 and CD26 in human lymphocytes. J. Biol. Chem. 276, 19,532–19,539.
Ishii, T., Ohnuma, K., Murakami, A., et al. (2001) CD26-mediated signalling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc. Natl. Acad. Sci. U.S.A. 98, 12,138–12,143.
Busek, P., Malik, R., and Sedo, A. (2004) Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. Int. J. Biochem. Cell Biol. 36, 408–421.
Kumagai, Y., Konishi, K., Gomi, T., Yagishita, H., Yajima, A., and Yoshikawa, M. (2000) Enzymatic properties of dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis and its participation in virulence. Infect. Immun. 68, 716–724.
Takahashi, N. and Sato, T. (2000) Preferential utilization of dipeptides by Porphyromonas gingivalis. J. Dent. Res. 80, 1425–1429.
Takahashi, N. and Sato, T. (2002) Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum. Oral Microbiol. Immunol. 17, 50–54.
Yagishita, H., Kumagai, Y., Konishi, K., Takahashi, Y., Aoba, T., and Yoshikawa, M. (2001) Histopathological studies on virulence of dipeptidyl aminopeptidase IV (DPPIV) of Porphyromonas gingivalis in a mouse abscess model: use of a DPPIV-deficient mutant. Infect. Immun. 69, 7159–7161.
Banbula, A., Bugno, M., Goldstein, J., et al. (2000) Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalin prolyl dipeptidyl peptidase IV. Infect. Immun. 68, 1176–1182.
Lambeir, A. M., Rea, D., Fülöp, V., et al. (2003) Exploration of the active site of dipeptidyl peptidase IV from Porphyromonas gingivalis. Comparison with the human enzyme. Adv. Exp. Med. Biol. 524, 29–35.
Rea, D., Lambeir, A. M., Kumagai, Y., De Meester, I., Scharpé, S., and Fülöp, V. (2004) Expression, purification and preliminary crystallographic analysis of dipeptidyl peptidase IV from Porphyromonas gingivalis. Acta Crystallogr. D 60, 1871–1873.
Aertgeerts, K., Ye, S., Tennant, M. G., et al. (2004) Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation. Protein Sci. 13, 412–421.
Brandstetter, H., Kim, J. S., Groll, M., and Huber, R. (2001) Crystal structure of the tricorn protease reveals a protein disassembly line. Nature 414, 466–470.
Kim, J. S., Groll, M., Musiol, H. J., et al. (2002) Navigation inside a protease: substrate selection and product exit in the tricorn protease from Thermoplasma acidophilum. J. Mol. Biol. 324, 1041–1050.
Abbott, C. A., McCaughan, G. W., and Gorrell, M. D. (1999) Two highly conserved glutamic acid residues in the predicted β-propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett. 458, 278–284.
Bjelke, J. R., Christensen, J., Branner, S., et al. (2004) Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV. J. Biol. Chem. 279, 34,691–34,697.
Hanski, C., Huhle, T., Gossrau, R., and Reutter, W. (1998) Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Exp. Cell. Res. 178, 64–72.
Gorrell, M. D., Gysbers, V., and McCaughan, G. W. (2001) CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand. J. Immunol. 54, 249–264.
Von Bonin, A., Huhn, J., and Fleischer, B. (1998) Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol. Rev. 161, 43–53.
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., and Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261, 466–469.
Schrader, W. P., West, C. A., Miczek, A. D., and Norton, E. K. (1990) Characterization of the adenosine deaminase-adenosine deaminase complexing protein binding reaction. J. Biol. Chem. 265, 19,312–19,318.
Weihofen, W. A., Liu, J., Reutter, W., Saenger, W., and Fan, H. (2004) Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface. J. Biol. Chem. 279, 43,330–43,335.
De Meester, I., Vanham, G., Kestens, L., et al. (1994) Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24, 566–570.
Gines, S., Marin, M., Mallol, J., et al. (2002) Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Biochem. J. 361, 203–209.
Strop, P., Bankovich, A. J., Hansen, K. C., Garcia, K. C., and Brünger, A. T. (2004) Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family. J. Mol. Biol. 343, 1055–1065.
Nadal, M. S., Ozaita, A., Amarillo, Y., et al. (2003). The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels. Neuron 37, 449–461.
Jerng, H. H., Qian, Y., and Pfaffinger, P. J. (2004) Modulation of Kv4.2 channel expression and gating by dipeptidyl peptidase 10 (DPP10). Biophys. J. 87, 2380–2396.
Jones, W. M., Scaloni, A., and Manning, J. M. (1994) Acylaminoacyl-peptidase. Methods Enzymol. 244, 227–231.
Jones, W. M., Manning, L. R., and Manning, J. M. (1986) Enzymic cleavage of the blocked amino terminal residues of peptides. Biochem. Biophys. Res. Commun. 139, 244–250.
Jones, W. M., Scaloni, A., Bossa, F., Popowicz, A. M., Schneewind, O., and Manning, J. M. (1991) Genetic relationship between acylpeptide hydrolase and acylase, two hydrolytic enzymes with similar binding but different catalytic specificities. Proc. Natl. Acad. Sci. U.S.A. 88, 2194–2198.
Farries, T. C., Harris, A., Auffret, A. D., and Aitken, A. (1991) Removal of N-acetyl groups from blocked peptides with acylpeptide hydrolase. Stabilization of the enzyme and its application to protein sequencing. Eur. J. Biochem. 196, 679–685.
Naylor, S. L., Marshall, A., Hensel, C., Martinez, P. F., Holley, B., and Sakaguchi A. Y. (1989) The DNF15S2 locus at 3p21 is transcribed in normal lung small cell lung cancer. Genomics 4, 355–361.
Erlandsson, R., Boldog, F., Persson, B., et al. (1991) The gene from the short arm of chromosome 3, at D3F15S2, frequently deleted in renal cell carcinoma, encodes acylpeptide hydrolase. Oncogene 6, 1293–1295.
Scaloni A., Jones, W. M., Pospischil, M., et al. (1992) Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell lines. J. Lab. Clin. Med. 120, 546–552.
Duysen, E. G., Li, B., Xie, W., et al. (2001) Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J. Pharmacol. Exp. Ther. 299, 528–535.
Richards, P. G., Johnson, M. K., and Ray, D. E. (2000) Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. Mol. Pharmacol. 58, 577–583.
Mitta, M., Miyagi, M., Kato, I., and Tsunasawa, S. (1998) Identification of the catalytic triad residues of porcine liver acylamino acid-releasing enzyme. J. Biochem. 123, 924–931.
Raphel, V., Giardina, T., Guevel, L., et al. (1999) Cloning, sequencing and further characterization of acylpeptide hydrolase from porcine intestinal mucosa. Biochim. Biophys. Acta 1432, 371–381.
Kiss, A. L., Szeltner, Z., Fülöp, V., and Polgár, L. (2004). His507 of acylaminoacyl peptidase stabilizes the active site conformation, not the catalytic intermediate. FEBS Lett. 571, 17–20.
Feese, M., Scaloni, A., Jones, W. M., Manning, J. M., and Remington, S. J. (1993) Crystallization and preliminary X-ray studies of human erythrocyte acylpeptide hydrolase. J. Mol. Biol. 233, 546–549.
Durand, A., Villard, C., Giardina, T., Perrier, J., Juge, N., and Puigserver, A. (2003) Structural properties of porcine intestine acylpeptide hydrolase. J. Protein Chem. 22, 183–191.
Wang, G., Gao, R., Ding, Y., et al. (2002) Crystallization and preliminary crystallographic analysis of acylamino-acid releasing enzyme from the hyperthermophilic archaeon Aeropyrum pernix. Acta Crystallogr. D 58, 1054–1055.
Bartlam, M., Wang, G., Yang, H., et al. (2004) Crystal structure of an acylpeptide hydrolase/esterase from Aeropyrum pernix K1. Structure 12, 1481–1488.
Laing, W. A. and Christeller, J. T. (1997) A plant chloroplast glutamyl proteinase. Plant Physiol. 114, 715–722.
Yamauchi, Y., Ejiri, Y., Sugimoto, T., Sueyoshi, K., Oji, Y., and Tanaka, K. (2001) A high molecular weight glutamyl endopeptidase and its endogenous inhibitors from cucumber leaves. J. Biochem. 130, 257–261.
Esnouf, R. M. (1997) An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. 15, 133–138.
Kraulis, P. J. (1991) MolScript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946–950.
Merritt, E. A. and Murphy, M. E. P. (1994) Raster3D version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869–873.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rea, D., Fülöp, V. Structure-function properties of prolyl oligopeptidase family enzymes. Cell Biochem Biophys 44, 349–365 (2006). https://doi.org/10.1385/CBB:44:3:349
Issue Date:
DOI: https://doi.org/10.1385/CBB:44:3:349